Malaria: Relative Bioavailability and Food Effect of DSM265

Condition:   Healthy Volunteers Interventions:   Drug: DSM265-TPGS 34% SDD, 400 mg fasted;   Drug: DSM265-TPGS 34% SDD, 400 mg fed;   Drug: DSM265 25% SDD, 400 mg fasted Sponsors:   Medicines for Malaria Venture;   AbbVie Not yet recruiting

Source: ClinicalTrials.gov - August 20, 2018 Category: Research Source Type: clinical trials